The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Susceptibility Pathways in Fanconi's Anemia and Breast Cancer
Open accessAbstract
Fanconi's anemia is a rare disorder that arises from defective repair of damaged DNA. Of the 13 Fanconi's anemia genes, 3 are breast-cancer–susceptibility genes. One is identical to BRCA2. Cells from patients with the D1 subtype of Fanconi's anemia and their family members carry biallelic mutations in BRCA2, and heterozygote members of kindreds with the D1 subtype have an increased risk of breast and ovarian cancer. Studies of a rare disorder can thus illuminate a common disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802
DNA repair pathways as targets for cancer therapy
Helleday, T., Petermann, E., Lundin, C., Hodgson, B., & Sharma, R. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2342 · Cited by 1,666
Hallmarks of 'BRCAness' in sporadic cancers
Turner, N., Tutt, A., & Ashworth, A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1457 · Cited by 1,657
McCabe, N., Turner, N. C., Lord, C. J., Kluzek, K., Białkowska, A., Swift, S., Giavara, S., O'Connor, M. J., Tutt, A. N., Zdzienicka, M. Z., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0140 · Cited by 1,310
Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198
Self-citationBiallelic Inactivation of BRCA2 in Fanconi Anemia
Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002) · Science · doi:10.1126/science.1073834 · Cited by 1,149
Self-citationSecondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
Sakai, W., Swisher, E. M., Karlan, B. Y., Agarwal, M. K., Higgins, J., Friedman, C., Villegas, E., Jacquemont, C., Farrugia, D. J., Couch, F. J., et al. (2008) · Nature · doi:10.1038/nature06633 · Cited by 1,086
Resistance to therapy caused by intragenic deletion in BRCA2
Edwards, S. L., Brough, R., Lord, C. J., Natrajan, R., Vatcheva, R., Levine, D. A., Boyd, J., Reis-Filho, J. S., & Ashworth, A. (2008) · Nature · doi:10.1038/nature06548 · Cited by 1,011
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Jones, S., Hruban, R. H., Kamiyama, M., Borges, M., Zhang, X., Parsons, D. W., Lin, J. C.-H., Palmisano, E., Brune, K., Jaffee, E. M., et al. (2009) · Science · doi:10.1126/science.1171202 · Cited by 826
The Fanconi anaemia/BRCA pathway
D'Andrea, A. D., & Grompe, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc970 · Cited by 822
Self-citationBRCA2 Function in DNA Binding and Recombination from a BRCA2-DSS1-ssDNA Structure
Yang, H., Jeffrey, P. D., Miller, J., Kinnucan, E., Sun, Y., Thomä, N. H., Zheng, N., Chen, P.-L., Lee, W.-H., & Pavletich, N. P. (2002) · Science · doi:10.1126/science.297.5588.1837 · Cited by 705
Identification of the FANCI Protein, a Monoubiquitinated FANCD2 Paralog Required for DNA Repair
Smogorzewska, A., Matsuoka, S., Vinciguerra, P., McDonald, E. R., Hurov, K. E., Luo, J., Ballif, B. A., Gygi, S. P., Hofmann, K., D'Andrea, A. D., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.009 · Cited by 700
Self-citationDisease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells
Raya, Á., Rodríguez-Pizà, I., Guenechea, G., Vassena, R., Navarro, S., Barrero, M. J., Consiglio, A., Castellà, M., Río, P., Sleep, E., et al. (2009) · Nature · doi:10.1038/nature08129 · Cited by 696
Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins
Wang, W. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2159 · Cited by 663
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Reid, S., Schindler, D., Hanenberg, H., Barker, K., Hanks, S., Kalb, R., Neveling, K., Kelly, P., Seal, S., Freund, M., et al. (2007) · Nature Genetics · doi:10.1038/ng1947 · Cited by 642
Involvement of Brca2 in DNA Repair
Patel, K. J., Yu, V. P. C. C., Lee, H., Corcoran, A., Thistlethwaite, F. C., Evans, M. J., Colledge, W. H., Friedman, L. S., Ponder, B. A. J., & Venkitaraman, A. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80035-0 · Cited by 634
Chen, J., Silver, D. P., Walpita, D., Cantor, S. B., Gazdar, A. F., Tomlinson, G., Couch, F. J., Weber, B. L., Ashley, T., Livingston, D. M., et al. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80276-2 · Cited by 633
A 20-year perspective on the International Fanconi Anemia Registry (IFAR)
Kutler, D. I., Singh, B., Satagopan, J., Batish, S. D., Berwick, M., Giampietro, P. F., Hanenberg, H., & Auerbach, A. D. (2003) · Blood · doi:10.1182/blood-2002-07-2170 · Cited by 618
PALB2 is an integral component of the BRCA complex required for homologous recombination repair
Sy, S. M. H., Huen, M. S. Y., & Chen, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811159106 · Cited by 614
How the Fanconi Anemia Pathway Guards the Genome
Moldovan, G.-L., & D'Andrea, A. D. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134222 · Cited by 590
Self-citationThe Deubiquitinating Enzyme USP1 Regulates the Fanconi Anemia Pathway
Nijman, S. M. B., Huang, T. T., Dirac, A. M. G., Brummelkamp, T. R., Kerkhoven, R. M., D'Andrea, A. D., & Bernards, R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.01.008 · Cited by 588
Self-citationRegulation of monoubiquitinated PCNA by DUB autocleavage
Huang, T. T., Nijman, S. M. B., Mirchandani, K. D., Galardy, P. J., Cohn, M. A., Haas, W., Gygi, S. P., Ploegh, H. L., Bernards, R., & D'Andrea, A. D. (2006) · Nature Cell Biology · doi:10.1038/ncb1378 · Cited by 581
Self-citationA novel ubiquitin ligase is deficient in Fanconi anemia
Meetei, A. R., de Winter, J. P., Medhurst, A. L., Wallisch, M., Waisfisz, Q., van de Vrugt, H. J., Oostra, A. B., Yan, Z., Ling, C., Bishop, C. E., et al. (2003) · Nature Genetics · doi:10.1038/ng1241 · Cited by 568
Inherited Susceptibility to Common Cancers
Foulkes, W. D. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0802968 · Cited by 563
PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
Zhang, F., Ma, J., Wu, J., Ye, L., Cai, H., Xia, B., & Yu, X. (2009) · Current Biology · doi:10.1016/j.cub.2009.02.018 · Cited by 562
Fanconi anemia and its diagnosis
Auerbach, A. D. (2009) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2009.01.013 · Cited by 562
Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors
Taniguchi, T., Tischkowitz, M., Ameziane, N., Hodgson, S. V., Mathew, C. G., Joenje, H., Mok, S. C., & D'Andrea, A. D. (2003) · Nature Medicine · doi:10.1038/nm852 · Cited by 536
Self-citationThe Fanconi Anemia Pathway Promotes Replication-Dependent DNA Interstrand Cross-Link Repair
Knipscheer, P., Räschle, M., Smogorzewska, A., Enoiu, M., Ho, T. V., Schärer, O. D., Elledge, S. J., & Walter, J. C. (2009) · Science · doi:10.1126/science.1182372 · Cited by 518
Preimplantation Diagnosis for Fanconi Anemia Combined With HLA Matching
Verlinsky, Y. (2001) · JAMA · doi:10.1001/jama.285.24.3130 · Cited by 488
The emerging landscape of breast cancer susceptibility
Stratton, M. R., & Rahman, N. (2008) · Nature Genetics · doi:10.1038/ng.2007.53 · Cited by 487
BRCA2 germline mutations in familial pancreatic carcinoma
Hahn, S. A., Greenhalf, B., Ellis, I., Sina-Frey, M., Rieder, H., Korte, B., Gerdes, B., Kress, R., Ziegler, A., Raeburn, J. A., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.3.214 · Cited by 480
Fanconi anemia is associated with a defect in the BRCA2 partner PALB2
Xia, B., Dorsman, J. C., Ameziane, N., de Vries, Y., Rooimans, M. A., Sheng, Q., Pals, G., Errami, A., Gluckman, E., Llera, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1942 · Cited by 465
Meetei, A. R., Medhurst, A. L., Ling, C., Xue, Y., Singh, T. R., Bier, P., Steltenpool, J., Stone, S., Dokal, I., Mathew, C. G., et al. (2005) · Nature Genetics · doi:10.1038/ng1626 · Cited by 455
Convergence of the Fanconi Anemia and Ataxia Telangiectasia Signaling Pathways
Taniguchi, T., Garcia-Higuera, I., Xu, B., Andreassen, P. R., Gregory, R. C., Kim, S.-T., Lane, W. S., Kastan, M. B., & D'Andrea, A. D. (2002) · Cell · doi:10.1016/s0092-8674(02)00747-x · Cited by 449
Self-citationThe DNA helicase BRIP1 is defective in Fanconi anemia complementation group J
Levitus, M., Waisfisz, Q., Godthelp, B. C., Vries, Y. D., Hussain, S., Wiegant, W. W., Elghalbzouri-Maghrani, E., Steltenpool, J., Rooimans, M. A., Pals, G., et al. (2005) · Nature Genetics · doi:10.1038/ng1625 · Cited by 432
ATR couples FANCD2 monoubiquitination to the DNA-damage response
Andreassen, P. R., D'Andrea, A. D., & Taniguchi, T. (2004) · Genes & Development · doi:10.1101/gad.1196104 · Cited by 408
Self-citationPositional Cloning of a Novel Fanconi Anemia Gene, FANCD2
Timmers, C., Taniguchi, T., Hejna, J., Reifsteck, C., Lucas, L., Bruun, D., Thayer, M., Cox, B., Olson, S., D'Andrea, A. D., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00172-1 · Cited by 404
Self-citationLitman, R., Peng, M., Jin, Z., Zhang, F., Zhang, J., Powell, S., Andreassen, P. R., & Cantor, S. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.004 · Cited by 396
The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia
Levran, O., Attwooll, C., Henry, R. T., Milton, K. L., Neveling, K., Rio, P., Batish, S. D., Kalb, R., Velleuer, E., Barral, S., et al. (2005) · Nature Genetics · doi:10.1038/ng1624 · Cited by 370
BRCA2 mutations in primary breast and ovarian cancers
Lancaster, J. M., Wooster, R., Mangion, J., Phelan, C. M., Cochran, C., Gumbs, C., Seal, S., Barfoot, R., Collins, N., Bignell, G., et al. (1996) · Nature Genetics · doi:10.1038/ng0696-238 · Cited by 360
A UAF1-Containing Multisubunit Protein Complex Regulates the Fanconi Anemia Pathway
Cohn, M. A., Kowal, P., Yang, K., Haas, W., Huang, T. T., Gygi, S. P., & D'Andrea, A. D. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.09.031 · Cited by 357
Self-citationNaim, V., & Rosselli, F. (2009) · Nature Cell Biology · doi:10.1038/ncb1883 · Cited by 338
Identification of FAAP24, a Fanconi Anemia Core Complex Protein that Interacts with FANCM
Ciccia, A., Ling, C., Coulthard, R., Yan, Z., Xue, Y., Meetei, A. R., Laghmani, E. H., Joenje, H., McDonald, N., de Winter, J. P., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.003 · Cited by 321
Targeted therapy for cancer using PARP inhibitors
Lord, C. J., & Ashworth, A. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.06.016 · Cited by 289
Fanconi anemia diagnosis and the diepoxybutane (DEB) test.
Auerbach, A. D. (1993) · PubMed · Cited by 288
FANCI is a second monoubiquitinated member of the Fanconi anemia pathway
Sims, A. E., Spiteri, E., Sims, R. J., Arita, A. G., Lach, F. P., Landers, T., Wurm, M., Freund, M., Neveling, K., Hanenberg, H., et al. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1252 · Cited by 276
Interaction of FANCD2 and NBS1 in the DNA damage response
Nakanishi, K., Taniguchi, T., Ranganathan, V., New, H. V., Moreau, L. A., Stotsky, M., Mathew, C. G., Kastan, M. B., Weaver, D. T., & D'Andrea, A. D. (2002) · Nature Cell Biology · doi:10.1038/ncb879 · Cited by 272
Self-citationFanconi anemia gene mutations in young-onset pancreatic cancer.
van der Heijden, M. S., Yeo, C. J., Hruban, R. H., & Kern, S. E. (2003) · PubMed · Cited by 264
CpG Island Methylation of DNA Damage Response Genes in Advanced Ovarian Cancer
Teodoridis, J. M., Hall, J., Marsh, S., Kannall, H. D., Smyth, C., Curto, J., Siddiqui, N., Gabra, H., McLeod, H. L., Strathdee, G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1187 · Cited by 256
Inactivation of Murine Usp1 Results in Genomic Instability and a Fanconi Anemia Phenotype
Kim, J. M., Parmar, K., Huang, M., Weinstock, D. M., Ruit, C. A., Kutok, J. L., & D'Andrea, A. D. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.001 · Cited by 247
Self-citationFANCM Connects the Genome Instability Disorders Bloom's Syndrome and Fanconi Anemia
Deans, A. J., & West, S. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.12.006 · Cited by 247
Alter, B. P., Greene, M. H., Velazquez, I., & Rosenberg, P. S. (2003) · Blood · doi:10.1182/blood-2002-11-3597 · Cited by 244
Cantor, S., Drapkin, R., Zhang, F., Lin, Y., Han, J., Pamidi, S., & Livingston, D. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308717101 · Cited by 240
Diagnosis, Genetics, and Management of Inherited Bone Marrow Failure Syndromes
Alter, B. P. (2007) · Hematology · doi:10.1182/asheducation-2007.1.29 · Cited by 230
Marsit, C. J., Liu, M., Nelson, H. H., Posner, M., Suzuki, M., & Kelsey, K. T. (2004) · Oncogene · doi:10.1038/sj.onc.1207256 · Cited by 228
FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway
Ishiai, M., Kitao, H., Smogorzewska, A., Tomida, J., Kinomura, A., Uchida, E., Saberi, A., Kinoshita, E., Kinoshita-Kikuta, E., Koike, T., et al. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1504 · Cited by 222
Wagner, J. E. (2004) · Blood · doi:10.1182/blood-2003-09-3138 · Cited by 214
Bryant, H. E. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl108 · Cited by 212
Collis, S. J., Ciccia, A., Deans, A. J., Hořejší, Z., Martin, J. S., Maslen, S. L., Skehel, J. M., Elledge, S. J., West, S. C., & Boulton, S. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.10.014 · Cited by 211
Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways
Hussain, S. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh135 · Cited by 208
Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway
Chirnomas, D., Taniguchi, T., de la Vega, M., Vaidya, A. P., Vasserman, M., Hartman, A.-R., Kennedy, R., Foster, R., Mahoney, J., Seiden, M. V., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0493 · Cited by 207
Self-citationShared Genetic Susceptibility to Breast Cancer, Brain Tumors, and Fanconi Anemia
Offit, K., Levran, O., Mullaney, B., Mah, K., Nafa, K., Batish, S. D., Diotti, R., Schneider, H., Deffenbaugh, A., Scholl, T., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg072 · Cited by 201
Tracing the network connecting brca and fanconi anaemia proteins
Venkitaraman, A. R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1321 · Cited by 200
Deubiquitination of FANCD2 Is Required for DNA Crosslink Repair
Oestergaard, V. H., Langevin, F., Kuiken, H. J., Pace, P., Niedzwiedz, W., Simpson, L. J., Ohzeki, M., Takata, M., Sale, J. E., & Patel, K. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.09.020 · Cited by 199
Cell cycle–dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24
Kim, J. M., Kee, Y., Gurtan, A., & D'Andrea, A. D. (2008) · Blood · doi:10.1182/blood-2007-09-113092 · Cited by 193
Self-citationPromoter Hypermethylation of FANCF
Narayan, G., Arias-Pulido, H., Nandula, S. V., Basso, K., Sugirtharaj, D. D., Vargas, H., Mansukhani, M., Villella, J., Meyer, L., Schneider, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0245 · Cited by 190
Tischkowitz, M. D., Sabbaghian, N., Hamel, N., Borgida, A., Rosner, C., Taherian, N., Srivastava, A., Holter, S., Rothenmund, H., Ghadirian, P., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.055 · Cited by 189
Structural basis for recruitment of BRCA2 by PALB2
Oliver, A. W., Swift, S., Lord, C. J., Ashworth, A., & Pearl, L. H. (2009) · EMBO reports · doi:10.1038/embor.2009.126 · Cited by 180
Genetic Heterogeneity among Fanconi Anemia Heterozygotes and Risk of Cancer
Berwick, M., Satagopan, J. M., Ben‐Porat, L., Carlson, A. D., Mah, K., Henry, R., Diotti, R., Milton, K., Pujara, K., Landers, T., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1501 · Cited by 155
Bagby, G. C., & Alter, B. P. (2006) · Seminars in Hematology · doi:10.1053/j.seminhematol.2006.04.005 · Cited by 147
Germ Line Fanconi Anemia Complementation Group C Mutations and Pancreatic Cancer
Couch, F. J., Johnson, M. R., Rabe, K. G., Boardman, L., McWilliams, R. R., de Andrade, M., & Petersen, G. M. (2005) · Cancer Research · doi:10.1158/0008-5472.383.65.2 · Cited by 146
Identification of the Fanconi Anemia Complementation Group I Gene, FANCI
Dorsman, J. C., Levitus, M., Rockx, D., Rooimans, M. A., Oostra, A. B., Haitjema, A., Bakker, S. T., Steltenpool, J., Schuler, D., Mohan, S., et al. (2007) · Analytical Cellular Pathology · doi:10.1155/2007/151968 · Cited by 135
A novel diagnostic screen for defects in the Fanconi anemia pathway
Shimamura, A., Oca, R. M. D., Svenson, J. L., Haining, W. N., Moreau, L. A., Nathan, D. G., & D’Andrea, A. D. (2002) · Blood · doi:10.1182/blood-2002-05-1399 · Cited by 132
Self-citationFunctional Defects in the Fanconi Anemia Pathway in Pancreatic Cancer Cells
van der Heijden, M. S., Brody, J. R., Gallmeier, E., Cunningham, S. C., Dezentjé, D. A., Shen, D., Hruban, R. H., & Kern, S. E. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63329-9 · Cited by 129
CHK1 inhibition as a strategy for targeting fanconi anemia (FA) DNA repair pathway deficient tumors
Chen, C. C., Kennedy, R. D., Sidi, S., Look, A. T., & D’Andrea, A. D. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-24 · Cited by 129
Self-citationBLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks
Pichierri, P., Franchitto, A., & Rosselli, F. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600277 · Cited by 128
Papadopoulo, D., Guillouf, C., Mohrenweiser, H. W., & Moustacchi, E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8383 · Cited by 126
Diagnosis of Fanconi Anemia by Diepoxybutane Analysis
Auerbach, A. D. (2003) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0807s37 · Cited by 121
Elledge, S. J., & Amon, A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00041-7 · Cited by 119
Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1
Hussain, S. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg266 · Cited by 117
Swisher, E. M., Gonzalez, R. M., Taniguchi, T., Garcia, R. L., Walsh, T., Goff, B. A., & Welcsh, P. L. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-48 · Cited by 107
Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers
Rebbeck, T. R. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00269-1 · Cited by 95
FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3
Wilson, J. B., Yamamoto, K., Marriott, A. S., Hussain, S., Sung, P., Hoatlin, M. E., Mathew, C. G., Takata, M., Thompson, L., Kupfer, G. M., et al. (2008) · Oncogene · doi:10.1038/sj.onc.1211034 · Cited by 93
Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia
Tischkowitz, M. D., Morgan, N. V., Grimwade, D. J., Eddy, C.-A., Ball, S. E., Vořechovský, I., Langabeer, S. E., Stöger, R. J., Hodgson, S. V., & Mathew, C. G. (2004) · Leukemia · doi:10.1038/sj.leu.2403280 · Cited by 91
The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly
Mirchandani, K. D., McCaffrey, R. M., & D’Andrea, A. D. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.03.001 · Cited by 90
Self-citationShen, X. H., Do, H., Li, Y., Chung, W.-H., Tomasz, M., de Winter, J. P., Xia, B., Elledge, S. J., Wang, W., & Li, L. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.034 · Cited by 89
Dhillon, V. S., Shahid, M., & Husain, S. A. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-33 · Cited by 89
The Fanconi anemia (FA) pathway confers glioma resistance to DNA alkylating agents
Chen, C. C., Taniguchi, T., & D’Andrea, A. D. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0153-2 · Cited by 87
Self-citationWei, M., Xu, J., Dignam, J. J., Nanda, R., Sveen, L., Fackenthal, J. D., Grushko, T. A., & Olopade, O. I. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9766-6 · Cited by 83
The Fanconi anemia/BRCA pathway: A coordinator of cross-link repair
Mirchandani, K. D., & D’Andrea, A. D. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.06.014 · Cited by 82
Self-citationRosado, I. V., Niedźwiedź, W., Alpi, A. F., & Patel, K. J. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp365 · Cited by 77
Tempol Protects against Oxidative Damage and Delays Epithelial Tumor Onset in Fanconi Anemia Mice
Zhang, Q., Eaton, L., Snyder, E. R., Houghtaling, S. R., Mitchell, J. B., Finegold, M. J., Waes, C. V., & Grompe, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5186 · Cited by 74
Direct DNA Binding Activity of the Fanconi Anemia D2 Protein
Park, W.-H., Margossian, S. P., Horwitz, A. A., Simons, A. M., D’Andrea, A. D., & Parvin, J. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503730200 · Cited by 71
Self-citationBi‐allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia
Tischkowitz, M. D., Ameziane, N., Waisfisz, Q., de Winter, J. P., Harris, R., Taniguchi, T., D’Andrea, A. D., Hodgson, S. V., Mathew, C. G., & Joenje, H. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04640.x · Cited by 65
Self-citationA Growing Network of Cancer-Susceptibility Genes
Venkitaraman, A. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmcibr023150 · Cited by 65
Subtyping Analysis of Fanconi Anemia by Immunoblotting and Retroviral Gene Transfer
Pulsipher, M. A., Kupfer, G. M., Näf, D., Suliman, A., Lee, J.-S., Jakobs, P. M., Grompe, M., Joenje, H., Sieff, C. A., Guinan, E. C., et al. (1998) · Molecular Medicine · doi:10.1007/bf03401752 · Cited by 59
Self-citationZhi, G., Wilson, J. B., Chen, X., Krause, D. S., Xiao, Y., Jones, N. J., & Kupfer, G. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2312 · Cited by 58
Poly(ADP-ribose) polymerase inhibitors as potential chemotherapeutic agents
Bryant, H. E., & Helleday, T. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320959 · Cited by 53
Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells
Xie, Y., de Winter, J. P., Waisfisz, Q., Nieuwint, A. W. M., Scheper, R. J., Arwert, F., Hoatlin, M. E., Ossenkoppele, G. J., Schuurhuis, G., & Joenje, H. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02450.x · Cited by 43
Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia.
Hess, C. J., Ameziane, N., Schuurhuis, G. J., Errami, A., Denkers, F., Kaspers, G. J. L., Cloos, J. J., Joenje, H., Reinhardt, D., Ossenkoppele, G. J., et al. (2008) · PubMed Central · doi:10.3233/clo-2008-0426 · Cited by 43
The Fanconi Anemia Signalosome Anchor
Niedernhofer, L. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.002 · Cited by 37
A novel cell‐free screen identifies a potent inhibitor of the Fanconi anemia pathway
Landais, I., Sobeck, A., Stone, S., LaChapelle, A., & Hoatlin, M. E. (2008) · International Journal of Cancer · doi:10.1002/ijc.24039 · Cited by 37
The Two Faces of BRCA2, a FANCtastic Discovery
Stewart, G. S., & Elledge, S. J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00580-4 · Cited by 34
The Fanconi Family Adds a Fraternal Twin
Grompe, M., & van de Vrugt, H. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.04.008 · Cited by 31
BRCA-FA Pathway as a Target for Anti-Tumor Drugs
Flynn, R. L., Gupta, R., Brosh, R. M., & Cantor, S. B. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008784220285 · Cited by 25
Familial pancreatic cancer: from genes to improved patient care
Hruban, R. H., Klein, A. P., Eshleman, J. R., Axilbund, J. E., & Goggins, M. (2007) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.1.1.81 · Cited by 19
Gallmeier, E., Hucl, T., Brody, J. R., Dezentjé, D. A., Tahir, K. S., Kašpárková, J., Brabec, V., Bachman, K. E., & Kern, S. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2711 · Cited by 16
Gene therapy in the treatment of Fanconi anemia, a progressive bone marrow failure syndrome.
Williams, D. A., Croop, J. M., & Kelly, P. F. (2005) · PubMed · Cited by 14
Subtyping of Fanconi anemia patients: implications for clinical management
Shimamura, A., & D’Andrea, A. D. (2003) · Blood · doi:10.1182/blood-2003-04-1297 · Cited by 13
Self-citationZhu, A. X., D’Andrea, A. D., Sahani, D. V., & Hasserjian, R. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmcpc069004 · Cited by 7
Self-citation
Cited by
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Murai, J., Huang, S.-Y. N., Das, B. B., Renaud, A., Zhang, Y., Doroshow, J. H., Ji, J., Takeda, S., & Pommier, Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2753 · Cited by 2,192
Mechanisms of DNA damage, repair, and mutagenesis
Chatterjee, N., & Walker, G. C. (2017) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22087 · Cited by 2,039
Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
Konstantinopoulos, P. A., Ceccaldi, R., Shapiro, G. I., & D'Andrea, A. D. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0714 · Cited by 945
Self-citationSchlacher, K., Wu, H., & Jasin, M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.015 · Cited by 936
Walsh, T., Casadei, S., Lee, M. K., Pennil, C. C., Nord, A. S., Thornton, A. M., Roeb, W., Agnew, K. J., Stray, S. M., Wickramanayake, A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115052108 · Cited by 933
Metadata
- Authors
- D'Andrea, A. D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-05-20
- Volume
- 362
- Issue
- 20
- Pages
- 1909-1919
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2052215590
- Cited by
- 381
- References
- 115
- FWCI
- 23.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.